Renal Cell Carcinoma News and Research

Latest Renal Cell Carcinoma News and Research

Rutgers research reveals mechanism to prevent benign kidney tumor from becoming cancerous

Rutgers research reveals mechanism to prevent benign kidney tumor from becoming cancerous

Meat-rich diet may increase kidney cancer risk

Meat-rich diet may increase kidney cancer risk

Brain metastases evolve ‘clinically actionable’ mutations

Brain metastases evolve ‘clinically actionable’ mutations

Cabozantinib, nivolumab ‘bring hope’ for advanced RCC patients

Cabozantinib, nivolumab ‘bring hope’ for advanced RCC patients

New drug works better than current treatments for advanced kidney cancer

New drug works better than current treatments for advanced kidney cancer

Nivolumab drug significantly prolongs survival in advanced kidney cancer patients

Nivolumab drug significantly prolongs survival in advanced kidney cancer patients

Patients with advanced kidney cancer benefit from cabozantinib treatment

Patients with advanced kidney cancer benefit from cabozantinib treatment

Immune checkpoint inhibitor increases survival in patients with advanced renal cell carcinoma

Immune checkpoint inhibitor increases survival in patients with advanced renal cell carcinoma

CTCA at Western begins clinical trial that combines immunotherapy with chemotherapy to target sarcomas

CTCA at Western begins clinical trial that combines immunotherapy with chemotherapy to target sarcomas

Tolerability benefits with sunitinib schedule switch

Tolerability benefits with sunitinib schedule switch

First-line TKI adverse event profile has no bearing on second-line RCC treatment choice

First-line TKI adverse event profile has no bearing on second-line RCC treatment choice

Active surveillance ‘viable option’ for SRM management

Active surveillance ‘viable option’ for SRM management

Researchers find key cellular enzyme that could be effective drug target for urologic cancer cells

Researchers find key cellular enzyme that could be effective drug target for urologic cancer cells

Argos Therapeutics begins AGS-003 clinical trial in patients with metastatic renal cell carcinoma

Argos Therapeutics begins AGS-003 clinical trial in patients with metastatic renal cell carcinoma

CTCA at Western begins Phase Ib/II trial of new immunotherapy treatment for cancer patients

CTCA at Western begins Phase Ib/II trial of new immunotherapy treatment for cancer patients

IDMC recommends continuation of Argos’ ADAPT phase 3 trial of AGS-003 in mRCC patients

IDMC recommends continuation of Argos’ ADAPT phase 3 trial of AGS-003 in mRCC patients

Nivolumab and pembrolizumab therapies continue to show promise against advanced melanomas

Nivolumab and pembrolizumab therapies continue to show promise against advanced melanomas

Lenvatinib-everolimus combination extends PFS in patients with mRCC versus everolimus alone

Lenvatinib-everolimus combination extends PFS in patients with mRCC versus everolimus alone

AstraZeneca presents preliminary data from AZD6094-AZD9291 combination trial for treatment of NSCLC

AstraZeneca presents preliminary data from AZD6094-AZD9291 combination trial for treatment of NSCLC

Clinical utility of Caris Molecular Intelligence in five studies to be presented at ASCO 2015

Clinical utility of Caris Molecular Intelligence in five studies to be presented at ASCO 2015